Titre : Hymenolepis diminuta

Hymenolepis diminuta : Questions médicales fréquentes

Termes MeSH sélectionnés :

Controlled Substances
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hymenolepis diminuta : Questions médicales les plus fréquentes", "headline": "Hymenolepis diminuta : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hymenolepis diminuta : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-03", "dateModified": "2025-04-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hymenolepis diminuta" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hymenolepis", "url": "https://questionsmedicales.fr/mesh/D006926", "about": { "@type": "MedicalCondition", "name": "Hymenolepis", "code": { "@type": "MedicalCode", "code": "D006926", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.050.500.500.736.215.454" } } }, "about": { "@type": "MedicalCondition", "name": "Hymenolepis diminuta", "alternateName": "Hymenolepis diminuta", "code": { "@type": "MedicalCode", "code": "D048190", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Derek M McKay", "url": "https://questionsmedicales.fr/author/Derek%20M%20McKay", "affiliation": { "@type": "Organization", "name": "Department of Physiology and Pharmacology, Calvin, Joan, and Phoebe Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada." } }, { "@type": "Person", "name": "Anna Sulima-Celińska", "url": "https://questionsmedicales.fr/author/Anna%20Sulima-Celi%C5%84ska", "affiliation": { "@type": "Organization", "name": "Department of General Biology and Parasitology, Medical University of Warsaw, Warsaw, Poland." } }, { "@type": "Person", "name": "Daniel Młocicki", "url": "https://questionsmedicales.fr/author/Daniel%20M%C5%82ocicki", "affiliation": { "@type": "Organization", "name": "Department of General Biology and Parasitology, Medical University of Warsaw, Warsaw, Poland. daniel.mlocicki@wum.edu.pl." } }, { "@type": "Person", "name": "Uriel Koziol", "url": "https://questionsmedicales.fr/author/Uriel%20Koziol", "affiliation": { "@type": "Organization", "name": "Sección Biología Celular, Facultad de Ciencias, Universidad de la República, Montevideo 11400, Uruguay. Electronic address: ukoziol@gmail.com." } }, { "@type": "Person", "name": "Chaoqun Yao", "url": "https://questionsmedicales.fr/author/Chaoqun%20Yao", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences and One Health Center for Zoonoses and Tropical Veterinary Medicine, Ross Unive rsity School of Veterinary Medicine, P.O. Box 334, Basseterre, St. Kitts and Nevis." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Retrospective Cohort Study on Chronic Opioid Use After Geriatric Hip Fracture Surgery-Risk Factors, Trends, and Outcomes.", "datePublished": "2023-01-02", "url": "https://questionsmedicales.fr/article/36595589", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5435/JAAOS-D-22-00458" } }, { "@type": "ScholarlyArticle", "name": "Psychomodulatory substances: New legislative framework for control of psychoactive substances in Czechia.", "datePublished": "2024-10-09", "url": "https://questionsmedicales.fr/article/39388916", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.drugpo.2024.104603" } }, { "@type": "ScholarlyArticle", "name": "Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study.", "datePublished": "2023-06-09", "url": "https://questionsmedicales.fr/article/37348270", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.drugalcdep.2023.110819" } }, { "@type": "ScholarlyArticle", "name": "The Effect of Online Prescription Drug Monitoring on Opioid Prescription Habits After Elective Single-level Lumbar Fusion.", "datePublished": "2022-08-09", "url": "https://questionsmedicales.fr/article/35947832", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5435/JAAOS-D-22-00433" } }, { "@type": "ScholarlyArticle", "name": "Diverting Data and Drugs: A Narrative Review of the Mallinckrodt Documents.", "datePublished": "2024-05-31", "url": "https://questionsmedicales.fr/article/38818605", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/jme.2024.60" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Animaux", "item": "https://questionsmedicales.fr/mesh/D000818" }, { "@type": "ListItem", "position": 4, "name": "Invertébrés", "item": "https://questionsmedicales.fr/mesh/D007448" }, { "@type": "ListItem", "position": 5, "name": "Helminthes", "item": "https://questionsmedicales.fr/mesh/D006376" }, { "@type": "ListItem", "position": 6, "name": "Plathelminthes", "item": "https://questionsmedicales.fr/mesh/D010986" }, { "@type": "ListItem", "position": 7, "name": "Cestoda", "item": "https://questionsmedicales.fr/mesh/D002589" }, { "@type": "ListItem", "position": 8, "name": "Hymenolepis", "item": "https://questionsmedicales.fr/mesh/D006926" }, { "@type": "ListItem", "position": 9, "name": "Hymenolepis diminuta", "item": "https://questionsmedicales.fr/mesh/D048190" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hymenolepis diminuta - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hymenolepis diminuta", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hymenolepis diminuta", "description": "Comment diagnostiquer une infection par Hymenolepis diminuta ?\nQuels tests sont utilisés pour confirmer l'infection ?\nQuels symptômes peuvent indiquer une infection ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nQuelle est la méthode de référence pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hymenolepis diminuta", "description": "Quels sont les symptômes courants d'une infection ?\nL'infection peut-elle être asymptomatique ?\nLes enfants sont-ils plus touchés par les symptômes ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes peuvent-ils varier selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hymenolepis diminuta", "description": "Comment prévenir l'infection par Hymenolepis diminuta ?\nLes animaux de compagnie peuvent-ils transmettre le parasite ?\nFaut-il éviter certains aliments pour prévenir l'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes enfants doivent-ils être surveillés pour prévenir l'infection ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hymenolepis diminuta", "description": "Quel est le traitement standard pour Hymenolepis diminuta ?\nLes remèdes naturels sont-ils efficaces ?\nCombien de temps dure le traitement ?\nDes effets secondaires sont-ils associés au traitement ?\nLe traitement est-il efficace à 100 % ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hymenolepis diminuta", "description": "Quelles complications peuvent survenir avec l'infection ?\nL'infection peut-elle entraîner des problèmes de croissance chez les enfants ?\nY a-t-il un risque de réinfection ?\nLes infections chroniques peuvent-elles causer des complications ?\nLes complications sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hymenolepis diminuta", "description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLes enfants sont-ils plus vulnérables ?\nLe mode de vie urbain augmente-t-il le risque ?\nLes voyages dans des pays en développement sont-ils risqués ?", "url": "https://questionsmedicales.fr/mesh/D048190?mesh_terms=Controlled+Substances&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Hymenolepis diminuta ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par l'examen des selles pour détecter les œufs du parasite." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer l'infection ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de selles répétés et éventuellement une endoscopie peuvent être utilisés." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une infection ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des nausées et des diarrhées." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sanguins ne sont généralement pas utiles pour diagnostiquer cette infection." } }, { "@type": "Question", "name": "Quelle est la méthode de référence pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La méthode de référence est l'examen microscopique des selles pour les œufs." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une infection ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs abdominales, diarrhée, fatigue et perte de poids." } }, { "@type": "Question", "name": "L'infection peut-elle être asymptomatique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses personnes peuvent être infectées sans présenter de symptômes." } }, { "@type": "Question", "name": "Les enfants sont-ils plus touchés par les symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent présenter des symptômes plus marqués en raison de leur immunité." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à surveiller ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez les signes de déshydratation, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général." } }, { "@type": "Question", "name": "Comment prévenir l'infection par Hymenolepis diminuta ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une bonne hygiène, le lavage des mains et la cuisson des aliments." } }, { "@type": "Question", "name": "Les animaux de compagnie peuvent-ils transmettre le parasite ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les rongeurs peuvent être porteurs et transmettre le parasite aux humains." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments pour prévenir l'infection ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments crus ou mal cuits, surtout ceux susceptibles d'être contaminés." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où l'hygiène est insuffisante peut augmenter le risque d'infection." } }, { "@type": "Question", "name": "Les enfants doivent-ils être surveillés pour prévenir l'infection ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants doivent être surveillés pour leur hygiène, surtout après avoir joué dehors." } }, { "@type": "Question", "name": "Quel est le traitement standard pour Hymenolepis diminuta ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard est l'administration de médicaments antiparasitaires comme le praziquantel." } }, { "@type": "Question", "name": "Les remèdes naturels sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de preuves solides que les remèdes naturels soient efficaces contre cette infection." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dure généralement quelques jours, selon la gravité de l'infection." } }, { "@type": "Question", "name": "Des effets secondaires sont-ils associés au traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des nausées ou des douleurs abdominales peuvent survenir." } }, { "@type": "Question", "name": "Le traitement est-il efficace à 100 % ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est généralement efficace, mais des suivis sont nécessaires pour éviter les récidives." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'infection ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles digestifs graves et des carences nutritionnelles." } }, { "@type": "Question", "name": "L'infection peut-elle entraîner des problèmes de croissance chez les enfants ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'infection peut affecter la croissance et le développement des enfants." } }, { "@type": "Question", "name": "Y a-t-il un risque de réinfection ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans mesures préventives, le risque de réinfection est élevé." } }, { "@type": "Question", "name": "Les infections chroniques peuvent-elles causer des complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections chroniques peuvent entraîner des complications plus graves." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes immunodéprimées." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent une mauvaise hygiène, le contact avec des rongeurs et des aliments contaminés." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées sont plus susceptibles de développer des infections graves." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus vulnérables en raison de leur système immunitaire en développement." } }, { "@type": "Question", "name": "Le mode de vie urbain augmente-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre dans des zones urbaines avec des rongeurs peut augmenter le risque d'infection." } }, { "@type": "Question", "name": "Les voyages dans des pays en développement sont-ils risqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des pays avec de faibles normes d'hygiène augmentent le risque d'infection." } } ] } ] }

Sources (10000 au total)

A Retrospective Cohort Study on Chronic Opioid Use After Geriatric Hip Fracture Surgery-Risk Factors, Trends, and Outcomes.

The purpose of this study is to identify the risk factors for prolonged opioid use after surgery in geriatric hip fracture patients and the effects of prolonged use on mortality and readmission rates.... An institutional registry was queried for all patients older than 65 years who underwent surgical treatment of a hip fracture between January 2016 and June 2017. Using the Controlled Substance Utiliza... Of 500 patients who underwent hip-fracture surgery during the study period, a total of 322 had complete Controlled Substance Utilization Review and Evaluation System data. 36.0% (116) were OE, and 64.... Opioid use in geriatric hip fracture patients is high both preoperatively and postoperatively. Opioid exposed patients and patients on antidepressants are more likely to continue opioids at 6 months. ... Level III....

Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study.

Fentanyl- and methamphetamine-based counterfeit prescription drugs have driven escalating overdose death rates in the US, however their presence in Mexico has not been assessed. Our ethnographic team ... To characterize the availability of counterfeit and authentic controlled substances at pharmacies in Northern Mexico available to English-speaking tourists without a prescription.... We employed an iterative, exploratory, mixed methods design. Longitudinal ethnographic data was used to characterize tourist-oriented micro-neighborhoods and guide the selection of n=40 pharmacies in ... Of n=40 pharmacies, one or more of the requested controlled substances could be obtained with no prescription (as single pills or in bottles) at 28 (70.0%) and as single pills at 19 (47.5%). Counterfe... The availability of fentanyl-, heroin-, and methamphetamine-based counterfeit medications in tourist-oriented independent pharmacies in Northern Mexico represents a public health risk, and occurs in t...

The Effect of Online Prescription Drug Monitoring on Opioid Prescription Habits After Elective Single-level Lumbar Fusion.

The United States opioid epidemic is a well-documented crisis stemming from increased prescriptions of narcotics. Online prescription drug monitoring programs (PDMPs) are a potential resource to mitig... Patients who underwent a single-level lumbar fusion between August 27, 2017, and August 31, 2020, were identified and placed categorically into one of two cohorts: an "early adoption" cohort, Septembe... No significant difference was observed in preoperative opioid prescriptions between the early and late adoption cohorts. The late adoption group independently predicted decreased postoperative opioid ... PDMP implementation was associated with decreased postoperative opioid prescription patterns but not preoperative opioid prescribing behaviors.... 4....

Real or fake? Sourcing and marketing of non-prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia.

There is concern around non-prescribed benzodiazepine use, particularly with increasing detections of counterfeit products containing high-risk novel compounds. The aims of this study were to investig... Data were collected from a sample of Australians who inject drugs or use ecstasy and/or other illicit stimulants on a monthly or more frequent basis, and who reported past 6-month use of non-prescribe... Amongst participants who injected drugs, 71% reported that their last non-prescribed benzodiazepines were diverted from a known/trusted prescription, compared to 59% of participants who used ecstasy/o... Most participants obtained substances sold as classic/registered benzodiazepines, mostly via diverted prescriptions, with a substantial minority potentially unaware of counterfeits circulating. While ...

Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians: A Cluster Randomized Clinical Trial.

Tools that are directly integrated with the electronic health record (EHR) workflow can reduce the hassle cost of certain guideline-concordant practices, such as querying a prescription drug monitorin... To investigate the effect of integrating access to a PDMP within the EHR on the frequency of program queries by primary care clinicians.... The PRINCE (Prescribing Interventions for Chronic Pain Using the Electronic Health Record) randomized trial used a factorial cluster design at the clinic level in 43 primary care clinics in Minnesota.... Single sign-on access to the Minnesota PDMP was integrated into the EHR, allowing clinicians to query a patient's controlled substance prescription and dispensing history as recorded in the Minnesota ... Monthly PDMP query counts for primary care clinicians, overall and by modality (EHR-based, web-based, via a clinical delegate), adjusted for clinician characteristics, including type (physician, nurse... Of the 43 participating clinics with 309 clinicians, 21 clinics with 161 clinicians (102 [63.4%] women; 114 [70.8%] physicians; tenure, 10.6 [4.4] years) received the PDMP integration intervention. Ba... This cluster randomized clinical trial found that integrating access to the PDMP in the EHR increased PDMP-querying rates, suggesting that direct access reduced hassle costs and can dramatically impro... ClinicalTrials.gov Identifier: NCT04601506....

Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities.

While the mandate to check patients' prescription history in Prescription Drug Monitoring Program (PDMP) database before prescribing/dispensing controlled drugs has been shown to be an important tool ... Using data from Automated Reports and Consolidate Ordering System (ARCOS), we employed difference-in-differences design to estimate the association between PDMP use mandates and prescription stimulant... There was no evidence that limited PDMP use mandate was associated with a reduction in the prescription stimulant and depressant quantities. However, expansive PDMP use mandate that was non-specific t... Expansive PDMP use mandate was associated with a decline in prescription amphetamine quantity. Limited PDMP use mandate did not appear to change prescription stimulant and depressant quantities....

Review and inventory of 911 Good Samaritan Law Provisions in the United States.

911 Good Samaritan Laws (GSLs) confer limited legal immunity to bystanders in possession of controlled substances who report emergency overdoses. While these laws may decrease opioid overdose mortalit... We identified all state GSLs and their legislative history, characterizing features into four categories using a novel framework: breadth of protected activities, burden placed on Good Samaritans, str... GSLs vary substantially across states and time. Protections depend on the quantity of substances involved and may extend to the person experiencing the overdose or persons reporting their own overdose... States offer Good Samaritans substantially different protections even when the statutes confer nominally comparable immunities. Accommodating this heterogeneity will enhance the validity of future stu...